Book Online or Call 1-855-SAUSALITO

Sign In  |  Register  |  About Sausalito  |  Contact Us

Sausalito, CA
September 01, 2020 1:41pm
7-Day Forecast | Traffic

  • Search Hotels in Sausalito

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about edit

Recent news which mentions edit

< Previous 1 2 3 4 5 6 7 8 Next >
The 3 Most Promising Gene Editing Stocks to Buy in 2023
Tickers BEAM EDIT NTLA
Tags BEAM Market News NASDAQ:NTLA,NASDAQ:BEAM,NASDAQ:EDIT
From InvestorPlace
Why Shares of Editas Medicine Rose Monday
Tickers CRSP EDIT VRTX
Tags VRTX CRSP Recent Press Releases
From Motley Fool
Why Satsuma Pharmaceuticals Shares Are Trading Higher By 94%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Tickers ALLK ALLR BLBX BNGO
Tags Top Gainers MCRB MORF
From Benzinga
2 Stocks Under $15 Per Share to Consider
Tickers EDIT SNAP
Tags EDIT SNAP Market News
From Motley Fool
Why Are Gene-Editing Stocks CRSP, EDIT, NTLA Stock Up Today?
Tickers ARKK CRSP EDIT NTLA
Tags Market News Today's Market EDIT
From InvestorPlace
Why ViewRay Shares Are Trading Lower By 32%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Tickers AMST AUUD BBAI BFRG
Tags SANA Penny Stocks News
From Benzinga
Consolidated Communications, CRISPR Therapeutics And Other Big Stocks Moving Higher On Thursday
Tickers ALLO ALVR BANL CHGG
Tags Trading Ideas Industrials VERV
From Benzinga
Proceed With Caution When Considering These 5 Ultra-Popular Stocks
Tickers AMC EDIT NFLX SNDL
Tags NFLX AMC Recent Press Releases
From Motley Fool
Better Gene-Editing Stock: Editas Medicine vs. Bluebird Bio
Tickers BLUE CRSP EDIT
Tags EDIT CRSP Recent Press Releases
From Motley Fool
Can This Experimental Gene Therapy Be Enough to Lift Editas Medicine in the Future?
Tickers EDIT
Tags Recent Press Releases Market News EDIT
From Motley Fool
2 Reasons to Sell Editas Medicine Stock and 1 Reason to Buy It
Tickers EDIT
Tags Recent Press Releases Market News EDIT
From Motley Fool
7 Biotech Stocks to Buy for Breakthrough Treatments and Cures
Tickers BEAM CRSP EDIT LEGN
Tags Market News LEGN RARE
From InvestorPlace
The 3 Best CRISPR Stocks to Buy Now Before They Skyrocket
Tickers CRSP EDIT GILD GNOM
Tags NTLA VRTX CRSP
From InvestorPlace
Thinking of Buying Biotech Stocks? Do These 3 Things First
Tickers CRSP EDIT
Tags CRSP Market News Recent Press Releases
From Motley Fool
Editas Medicine Earnings Preview
Tickers EDIT
Tags EDIT BZI/EP Earnings
From Benzinga
These 2 Biotech Stocks Could Soar in the Next Bull Market
Tickers CRSP EDIT
Tags EDIT Market News Recent Press Releases
From Motley Fool
Is Exact Sciences or Editas Medicine the Better Growth Stock to Own in 2023?
Tickers EDIT EXAS
Tags EXAS Market News Recent Press Releases
From Motley Fool
3 No-Brainer Stocks to Buy Right Now for Less Than $25
Tickers EDIT EXEL IRWD
Tags IRWD EXEL EDIT
From Motley Fool
Why Editas Medicine's Shares Jumped This Week
Tickers CRSP EDIT VRTX
Tags VRTX CRSP Recent Press Releases
From Motley Fool
Is Editas Medicine Stock a Buy Now?
Tickers CRSP EDIT VRTX
Tags Recent Press Releases Market News VRTX
From Motley Fool
3 CRISPR Stocks to Buy Now Or You’ll Be Kicking Yourself Later
Tickers CRSP EDIT TXG
Tags EDIT NASDAQ:CRSP,NASDAQ:EDIT,NASDAQ:TXG Stocks to Buy
From InvestorPlace
Why Editas Medicine Stock Charged Higher in January
Tickers EDIT
Tags EDIT Market News Recent Press Releases
From Motley Fool
Analyst Initiates Coverage On This Peer Lagging Gene-Editing Stock
Tickers CRSP EDIT NTLA
Tags General Small Cap Biotech
From Benzinga
Expert Ratings for Editas Medicine
Tickers EDIT
Tags Benzinga Market News Analyst Ratings
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For February 1, 2023
Tickers AEP AMD APPS AQUA
Tags WTFC FNKO MCO
From Benzinga
7 CRISPR Stocks With the Best Long-Term Potential
Tickers BEAM BIIB CLLS CRSP
Tags VERV CLLS EDIT
From InvestorPlace
Why Shares of Editas Medicine Jumped This Week
Tickers EDIT
Tags Recent Press Releases Market News EDIT
From Motley Fool
Shoreline Biosciences Acquires Editas' iNK Cell Franchise, Related Gene Editing Technologies
Tickers EDIT
Tags Briefs EDIT News
From Benzinga
3 CRISPR Stocks That Will Make You Filthy Rich in 10 Years
Tickers CRSP EDIT GNOM
Tags Stocks to Buy EDIT CRSP
From InvestorPlace
Analyst Expectations for Editas Medicine's Future
Tickers EDIT
Tags Benzinga Market News EDIT
From Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Photos copyright by Jay Graham Photographer
Copyright © 2010-2020 Sausalito.com & California Media Partners, LLC. All rights reserved.